LEDERMAN SETH 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed May 15, 2025
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock, $0.001 par value
2025-05-15$21.55/sh+4,000$86,200→ 4,005 total
Holdings
- 1(indirect: By IRA)
Common Stock, $0.001 par value
- 1(indirect: Lederman & Co.)
Common Stock, $0.001 par value
Footnotes (1)
- [F1]Reporting person may be deemed to be a control person of this entity.